Literature DB >> 3670519

[Extrapyramidal syndrome in idiopathic hemochromatosis. Significance of laboratory chemical, neurophysiologic and imaging procedures (CCT, MRT)].

J Schröder1, J Haan.   

Abstract

In any patient with unexplained basal ganglia symptoms or dementia, the possibility of idiopathic hemochromatosis (IHC) should be considered. The findings of magnetic resonance tomography, discussed in this case report, lead to the conclusion that IHC is very likely to induce these syndromes. This is of clinical importance as IHC can be successfully treated by phlebotomy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670519

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  5 in total

1.  Hereditary hemochromatosis and movement disorders: the still controversial relationship. Response to Russo et al. in J Neurol (2004) 251:849-852.

Authors:  G Demarquay; S Thobois; P Latour; Emmanuel Broussolle
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

2.  Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association?

Authors:  M P Rutgers; A Pielen; M Gille
Journal:  J Neurol       Date:  2007-04-21       Impact factor: 4.849

3.  Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Authors:  Alfonso Fasano; Anna Rita Bentivoglio; Cesare Colosimo
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

4.  Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.

Authors:  S Akhlaghpoor; A Ghahari; A Morteza; O Khalilzadeh; A Shakourirad; M R Alinaghizadeh
Journal:  Clin Neuroradiol       Date:  2011-12-13       Impact factor: 3.649

Review 5.  Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review.

Authors:  Noemi Russo; Mark Edwards; Thomasin Andrews; Michael O'Brien; Kailash P Bhatia
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.